L

Leap Health

Transparent infusion benefits for self-funded employers

Head of Data Science & Analytics

Full-TimePosted on 10/16/2026
$200k - $250k/yr
Expert
Master's, PhD
Remote in USA
Remote
Data & AnalyticsData Science

About the job

Requirements
  • You have developed statistical or machine learning methods that informed real decisions or became part of operational workflows, and you have owned their validation and ongoing performance.
  • You have strong statistical foundations and experience with several relevant methods, such as hierarchical or Bayesian modeling, forecasting, survival analysis, causal inference, or simulation, and you know how to choose an approach that fits the data and the decision.
  • You have worked hands-on with large healthcare datasets, including claims or eligibility data, and understand their coding, timing, completeness, and interpretation challenges.
  • You have worked with functional leaders to define how outcomes and performance are measured, built a roadmap from their most important questions, and delivered the models, reporting, and quality controls that put it into use.
  • You have led data scientists or analysts, or built a substantial capability as an early technical hire, and want to remain close to the work.
  • You use artificial intelligence tools effectively while maintaining independent judgment, reproducibility, and appropriate validation.
Responsibilities
  • Develop methods for identifying patients who may benefit from Leap using medical and pharmacy claims, eligibility records, clinical information, and operational data.
  • Translate incomplete and fragmented observations into useful signals about therapy utilization, treatment status, care transitions, and opportunities for engagement.
  • Develop and validate models of patient engagement, treatment initiation, adherence, and persistence, with clear definitions of what the available data can reliably establish.
  • Evaluate models for accuracy, calibration, bias, and operational usefulness, accounting for missing data, claims lag, and differences across populations.
  • Partner with Engineering, Product, and Clinical Operations to bring validated methods into production workflows and monitor their performance over time.
  • Build population-level models that connect covered lives to specialty therapy utilization, serviceable members, active patients, and treatment volume.
  • Account for stochastic variation, sparse observations, population differences, and the outsized effect of individual patients and high-cost therapies.
  • Apply appropriate statistical methods—such as hierarchical models, time-to-event analysis, and simulation—to estimate outcomes and quantify uncertainty.
  • Forecast performance by client, therapy, and time period, distinguishing underlying trends from random variation and changes in data availability.
  • Backtest forecasts, investigate deviations, and translate results into decisions about procurement, clinical capacity, client strategy, and financial planning.
  • Develop defensible methodologies and algorithms for estimating Leap’s savings, patient adherence, access to care, and broader program impact.
  • Define appropriate baselines and counterfactuals, accounting for factors such as patient selection, treatment mix, site of care, drug pricing, and observation periods.
  • Establish a consistent relationship between pre-sale savings estimates, account forecasts, and realized results, making assumptions and sources of uncertainty explicit.
  • Design experiments and observational analyses to understand which engagement and care interventions improve outcomes.
  • Partner with Finance, Clinical, and Client Success leaders to make these methods reproducible, explainable, and useful for internal decisions and client reporting.
  • Work directly with functional leaders to identify their most important data science and operational questions, translating them into a shared roadmap for models, analyses, and reporting.
  • Build on Leap’s existing reporting infrastructure to support growing client and patient populations, more complex operations, and new business capabilities.
  • Partner with each team to develop reliable views of its performance, including volumes, conversion, capacity, timeliness, quality, and outcomes, with the ability to investigate what drives changes.
  • Strengthen shared definitions and calculations for core metrics—including member funnel stages, activation, treatments, adherence, and savings—so company-wide reporting and departmental views remain consistent.
  • Expand Omni and the underlying analytical models into a durable self-service environment, making validated metrics accessible across dashboards, ad hoc analyses, and AI-assisted queries.
  • Own the reporting lifecycle with data engineering and analytics counterparts: prioritize requirements, define acceptance criteria, validate outputs, support adoption, and maintain reporting as workflows evolve.
  • Maintain the business data dictionary and documentation of analytical methods and source lineage, with clear communication when definitions, sources, or methodologies change.
  • Establish standards for reviewing, testing, and validating models, analyses, and recurring reporting.
  • Partner with Engineering on checks for data completeness, freshness, identity matching, and reconciliation across systems.
  • Ensure important patient and operational events are captured and represented consistently throughout the analytical workflow.
  • Make results reproducible through shared calculation logic, version control, documented assumptions, and appropriate peer review.
  • Make changes in results understandable, distinguishing business movement from new data, source corrections, or methodological updates.
  • Set the scientific and analytical direction for Leap, balancing foundational capabilities with opportunities to deliver new value.
  • Hire, develop, and lead data scientists and analysts as the company grows.
  • Work closely with data engineering and product counterparts to translate analytical requirements into durable technical capabilities.
  • Communicate complex methods and findings clearly, helping colleagues understand both what the evidence supports and where uncertainty remains.
  • Build a culture of curiosity, rigor, and practical experimentation across the company.
Desired Qualifications
  • Experience in specialty pharmacy, payer, pharmacy benefit manager, actuarial, health benefits, or clinical outcomes analytics.
  • Experience identifying patient cohorts or treatment patterns from longitudinal healthcare data.
  • Experience measuring healthcare costs, adherence, or program impact using experimental or observational methods.
  • Experience forecasting low-frequency, high-cost events or heterogeneous populations with limited historical data.
  • Experience with analytical data modeling, semantic layers, and self-service reporting tools such as dbt, Omni, or Looker.
  • An advanced degree in statistics, biostatistics, computer science, applied mathematics, economics, epidemiology, or a related quantitative field, or equivalent applied experience.
  • Experience building in a fast-growing company.

About the company

Leap Health coordinates transparent, pass-through specialty infusion benefits for self-funded employers, reducing drug costs by up to 60%. The service pairs employees with licensed Care Guides (nurses and pharmacists) to manage the entire infusion process, including prior authorizations and care navigation, with options for home infusion or infusion centers. It avoids opaque drug markups and operates on a fee-for-service model without per-member-per-month or fixed admin fees, aiming to deliver a quick return on investment for clients from the first patient treated. Leap focuses on patient-centered care, simplifying access to infusion therapy and coordinating care through consultants, brokers, and TPAs across all 50 states, with growing coverage and a high NPS score (92). The company’s goal is to reduce specialty drug costs, improve access and convenience for employees, and provide transparent, value-based health benefits to self-funded employers.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

2023

Get referred to Leap Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • February 4, 2026, Leap said covered lives grew 25x year over year.
  • May 26, 2026, Alight added Leap to its Partner Network.
  • September 1, 2026, Leap announced Angle Health partnership and executive expansion.

What critics are saying

  • Castlight, Amwins, and Alight can bundle competing infusion partners inside existing channels.
  • Leap disclosed only a $4 million seed round; thin funding limits scale.
  • If savings or clinical outcomes disappoint, employers churn and the model stalls.

What makes Leap Health unique

  • Leap's pass-through specialty infusion pricing removes hidden drug markups for employers.
  • Home and nearby infusion coordination reduces hospital-site waste and employee disruption.
  • Alight Partner Network access broadens distribution through existing benefits administrators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

2%

2 year growth

2%
Alight
May 13th, 2026
Alight adds Cylinder and Leap to Partner Network.

Alight adds Cylinder and Leap to Partner Network. Jenna Jordan Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth, leave and point solutions, today announced the expansion of its Alight Partner Network with the addition of Cylinder Health and Leap, two partners that strengthen Alight's ability to help employers deliver high-impact health solutions. The Alight Partner Network offers a curated ecosystem of solutions designed to help employers deliver a more connected and engaging employee experience. With the addition of Cylinder and Leap, Alight enables clients to access trusted specialty solutions through their existing Alight relationship. "By welcoming Cylinder and Leap to the Alight Partner Network, we are enhancing our ability to deliver innovative, high-impact health solutions that address the evolving needs of our clients and their employees," said Jessica Borchik, SVP, Partner Strategy and Sales at Alight. "These partnerships reinforce our commitment to providing employers with access to trusted specialty solutions through a single, connected experience, helping organizations support the health and wellbeing of their workforce while managing costs effectively." Digestive health care with Cylinder Cylinder helps employers and health plans reduce avoidable digestive health costs by connecting employees to earlier, coordinated care. It delivers integrated virtual-first digestive health support across gastrointestinal (GI) conditions, nutrition and behavioral health, helping employees access personalized digestive care sooner while supporting better health outcomes and a more seamless care experience. Cylinder has demonstrated strong engagement and meaningful symptom improvement across employers and health plan populations, while helping members access earlier digestive health support before symptoms escalate into higher-cost care. In addition, Cylinder helps employees access the right digestive care faster by: * Accelerating access to personalized care. Structured digital intake and real-time symptom tracking support triage and enable individualized care from the start. * Supporting whole-person digestive health. An integrated virtual care team spanning gastroenterology, nutrition and gut-brain health delivers coordinated support across digestive health needs. * Maintaining continuity across the care journey. Coordinated referrals and provider communication help ensure a connected experience extends beyond visits. "GI conditions are among the largest and most overlooked cost drivers for employers, yet many employees still struggle to access timely, coordinated digestive health support," said Ryan Sloan, Chief Commercial Officer at Cylinder. "By working with Alight, we can help employers close critical gaps in digestive care access, connect employees to support earlier, and reduce avoidable utilization while improving the overall care experience." Infusion therapy with Leap Leap is a leading infusion therapy partner for self-funded employers, delivering high-quality specialty infusion care in the home and at convenience nearby infusion centers. By coordinating care, managing complex treatments, navigating benefits and transparent drug pricing with no markup, Leap improves the experience for patients while lowering total cost of care for employers. The result is more convenient care and improved adherence for employees with serious or chronic conditions and stronger clinical and financial outcomes for employers. "Specialty infusion has become one of the fastest-growing drivers of self-funded employer healthcare spend, while patients often pay the price in delayed treatment, unnecessary travel and fragmented care," said Rob LaHayne, Cofounder and Chief Commercial Officer, Leap. "By joining the Alight Partner Network, Leap brings greater transparency and convenience to infusion therapy, helping employers reduce costs while ensuring employees receive timely, convenient, coordinated care." The Alight Partner Network helps extend the breadth of employers' offerings for organizations to thrive and provide benefits that support health, wealth and leave. To learn more about Alight's Partner Network, visit alight.com. About Cylinder Cylinder is a virtual-first digestive health solution delivering personalized, clinician-backed care for the full spectrum of gastrointestinal (GI) conditions and symptoms, including GERD, ulcerative colitis, celiac disease, bloating, constipation, and more. With a dedicated care team that includes GI doctors, registered dietitians, and health coaches, Cylinder has supported more than 150,000 patients across all 50 states. Backed by published, peer-reviewed clinical results, Cylinder has demonstrated strong engagement, meaningful symptom improvement, and strong ROI for employer populations. Cylinder works with employers and health plans to improve access to digestive care, reduce avoidable utilization, and deliver a more connected care experience. Learn more at Cylinder Health. About Leap Leap is the leading transparent infusion benefit solution for self-funded employers. Leap eliminates hidden provider markups on specialty drugs and coordinates infusion care end-to-end, while delivering a personalized patient experience that earns a strong Net Promoter Score (NPS). Learn more at leaphealth.com and follow us on LinkedIn. Media contacts.

Leap Health
Feb 4th, 2026
Leap partners with Angle Health to simplify and transform infusion care

Leap partners with Angle Health to simplify and transform infusion care. Leap has partnered with Angle Health to make infusion care simpler, more transparent, and less disruptive for employers and the employees who rely on infusion therapy. Infusion is one of the fastest-growing cost categories in employer healthcare. Too often, the experience is opaque: unclear pricing, multiple vendors, and treatment that requires time away from work and home. This partnership brings a more connected experience, combining Angle's benefits platform with Leap's infusion expertise and coordination, so members can get to the right setting of care and employers have clearer visibility into what they're paying for. "We're able to proactively guide members to the right treatment setting, deliver a dramatically better care experience, and reduce costs for employers - all within a unified, easy-to-navigate benefits experience rather than a patchwork of disconnected vendors." - Rob LaHayne, Co-Founder, Leap Health. A big part of the opportunity is site of care. Many infusions still happen in hospitals or infusion centers, even when home infusion may be clinically appropriate. When care is delivered closer to home and with the right clinical support, it reduces disruption for members and helps employers manage cost more effectively. Read the full announcement here: What this partnership means * A more seamless experience: benefits and specialty infusion support that feels connected, not stitched together. * More cost transparency: Leap's pass-through approach helps eliminate hidden markups and gives employers clearer visibility. * Support finding the right setting of care: including at-home infusion when clinically appropriate, to reduce disruption and avoid unnecessary high-cost settings. * Better coordination for members: fewer handoffs, less confusion, and a smoother path from benefits to care delivery. "Partnering with Leap Health extends that mission into infusion care delivery. When people understand their options and are supported every step of the way, everyone wins." - Ty Wang, Co-Founder & CEO, Angle Health If you are a self-funded employer or broker and infusion spend is on your radar, contact Leap to see how Leap Health, Inc. can help. This post summarizes an announcement originally distributed via Business Wire. Read the full release here. More insights. News 02/04/2026 Leap posts 25x growth; expands executive team. NEW YORK, NY - February 4, 2026 - Leap, the leading infusion therapy partner for self-funded employe... Education 01/20/2026 Why specialty infusion costs are straining employer healthcare budgets. Specialty infusion costs are quietly becoming one of the most significant pressures on employer heal... Education 01/03/2026 The infusion cost crisis: why medical benefit drug spend keeps escalating. For employers, however, infusion care has quietly become one of the fastest-growing and least unders... News 12/02/2025 Leap joins the Castlight ecosystem to simplify infusion care. Leap has joined the Castlight ecosystem to give TPAs and employers a more transparent, predictable,... Insights 11/30/2025 Rebates, what rebates? Understanding pharmacy rebates for j-code drugs. Pharmacy rebates are manufacturer-paid discounts, typically negotiated behind Education 11/30/2025 Demystifying specialty drug pricing acronyms, and why they all fail employers. Behind the exorbitant costs of infusion therapies, you'll find layers of complexity - and three acrony... Clinical 11/27/2025 Safely infusing Immunoglobulin in the home setting: clinical considerations and best practices. Immunoglobulin (Ig) therapies are essential in the treatment of primary immunodeficiency (PID), chro... News 10/17/2025 Leap and Amwins partner to deliver low-cost, convenient infusion therapy. Leap and Amwins Rx, today announced a strategic collaboration that will bring significant benefits t... Case Study 07/29/2025 Bringing relief home for annie. Helping a working parent stay on track with infusion care Insights 07/27/2025 How Leap reduces the total cost of multiple sclerosis care. For patients requiring long-term MS infusions like Ocrevus or Tysabri, traditional hospital-based tr...